Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk

H. Lee Moffitt Cancer Center and Research Institute265 enrolled

Overview

This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultural beliefs), enabling resources (social support, cost/insurance coverage), and perceived need (perceived susceptibility, provider recommendation).

Study Type

OBSERVATIONAL

Enrollment

265

Conditions

Breast Cancer

Interventions

Self-Report SurveyBEHAVIORAL

The self-report survey will be created using the Health Services Utilization Model (HSUM)

Qualitative InterviewsBEHAVIORAL

Researchers will randomly select 30 participants from group 1 and will use semi structured qualitive interviews exploring factors impacting utilization of screening breast MRI

Eligibility

Sex: FEMALEMin age: 25 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Ability to speak/read English * Within 2 years of last screening mammogram * Pathogenic BRCA1/2 mutations OR estimated lifetime risk ≥20% per the National Cancer Institute (NCI) Breast Cancer Risk Assessment Tool (BCRAT) Exclusion Criteria: * Women who have received a prior diagnosis of breast cancer

Locations (2)

Georgetown Lombardi Comprehensive Cancer Center

Washington D.C., District of Columbia, United States

Moffitt Cancer Center

Tampa, Florida, United States

Outcomes

Primary Outcomes

Reporting Receipt of MRI Breast Screening at Any Time

Participant-reported receipt of screening breast MRI at any time in the past.

Time frame: Baseline

Reporting Receipt of MRI Breast Screening in the Last 24 Months

Participant-reported receipt of screening breast MRI in the last 24 months

Time frame: Baseline

Secondary Outcomes

Reporting Receipt of Mammogram

Participant-reported receipt of breast cancer screening mammogram in the last 24 months

Time frame: Baseline

Reporting Receipt of Ultrasound

Participant-reported receipt of breast cancer screening ultrasound in the last 24 months

Time frame: Baseline

Reporting Receipt of Chemoprevention

Participant-reported receipt of chemoprevention at any point in time (including currently receiving).

Time frame: Baseline

Reporting Receipt of Genetic Testing

Participant-reported receipt of genetic testing at any time in the past

Time frame: Baseline

Reporting Receipt of Genetic Counseling

Participant-reported receipt of genetic counseling at any time in the past

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.